Her primary areas of study are Breast cancer, Internal medicine, Oncology, Cancer and Prospective cohort study. Rulla M. Tamimi has included themes like Gynecology and Genome-wide association study in her Breast cancer study. Her Endocrinology research extends to the thematically linked field of Internal medicine.
Rulla M. Tamimi has researched Oncology in several fields, including Proportional hazards model, Logistic regression, Tissue microarray and Pathology. Her studies in Cancer integrate themes in fields like Multivariate analysis and Transcription factor. Her Prospective cohort study study integrates concerns from other disciplines, such as Young adult, Body mass index, Cohort study and Obstetrics.
Rulla M. Tamimi focuses on Breast cancer, Internal medicine, Oncology, Cancer and Prospective cohort study. The concepts of her Breast cancer study are interwoven with issues in Odds ratio, Gynecology and Confidence interval. Internal medicine is closely attributed to Endocrinology in her work.
Her Oncology study combines topics in areas such as Body mass index, Nurses' Health Study, Epidemiology, Logistic regression and Mammography. Her study looks at the intersection of Prospective cohort study and topics like Cohort study with Cohort. Her research in Estrogen receptor intersects with topics in Genome-wide association study, Tissue microarray and Androgen receptor.
Rulla M. Tamimi mainly investigates Breast cancer, Internal medicine, Oncology, Prospective cohort study and Confidence interval. The subject of her Breast cancer research is within the realm of Cancer. Her study in the fields of Surgical oncology under the domain of Oncology overlaps with other disciplines such as Risk assessment.
Her Prospective cohort study research integrates issues from Overweight, Obesity, Young adult, Stage and Orange juice. Her studies examine the connections between Confidence interval and genetics, as well as such issues in Confounding, with regards to Anthropometry. Her studies deal with areas such as Genome-wide association study and Cohort as well as Epidemiology.
Her main research concerns Breast cancer, Internal medicine, Oncology, Prospective cohort study and Confidence interval. Rulla M. Tamimi is studying Estrogen receptor, which is a component of Breast cancer. Her Oncology research incorporates elements of Polygenic risk score and Postprandial, Insulin.
Her biological study spans a wide range of topics, including Stage, Medical record, Node negative and Environmental health. Her Confidence interval research includes themes of Menopausal hormone therapy and Confounding. Her Odds ratio research focuses on subjects like Case-control study, which are linked to Genetic variation, Gene, Estrogen Receptor Status and Family history.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr.
The Lancet (2020)
HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers
Marc L. Mendillo;Sandro Santagata;Sandro Santagata;Martina Koeva;George W. Bell.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer.
Journal of the National Cancer Institute (2015)
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics
Montserrat Garcia-Closas;Per Hall;Heli Nevanlinna;Karen Pooley.
PLOS Genetics (2008)
The Adaptor Protein Paxillin Is Essential for Normal Development in the Mouse and Is a Critical Transducer of Fibronectin Signaling
Margit Hagel;Elizabeth L. George;Ann Kim;Rulla Tamimi.
Molecular and Cellular Biology (2002)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu;Shaheenah Dawood;Michelle D. Holmes;Laura C. Collins.
Clinical Cancer Research (2011)
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Rulla May Tamimi;Rulla May Tamimi;Heather Joanne Baer;Heather Joanne Baer;Jonathan Marotti;Mark Galan.
Breast Cancer Research (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: